NCT00483353
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
- Locations
-
- Pfizer Investigational Site London, England, United Kingdom
Clinical trial condition
Explore clinical trials studying Nose Diseases. Study availability and eligibility vary by location and protocol.
NCT00483353
NCT00132275
NCT00189449
NCT00413556
NCT00533637
NCT00474890
NCT00441246
NCT00355771
NCT00439712
NCT00534768